BTAIVSSLXN• 6 Months (Normalized)
BTAI vs SLXN (BioXcel Therapeutics Inc. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-96.9%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
SLXN Performance $0.32
+%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin SLXN LEADS
-96.9 pts
SLXN outperforming by 96.90 percentage points
BTAISLXN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(120 dates)
| Date | BTAI Price | BTAI Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.04 | -96.90% | $- | - | |
| Sep 23, 2026 | $0.05 | -96.05% | $0.32 | -97.26% | +1.21% |
| Sep 22, 2026 | $0.04 | -96.09% | $0.39 | -96.59% | +0.50% |
| Sep 21, 2026 | $0.06 | -94.61% | $0.54 | -95.27% | +0.66% |
| Sep 18, 2026 | $0.06 | -94.91% | $0.44 | -96.21% | +1.30% |
| Sep 17, 2026 | $0.08 | -93.41% | $0.38 | -96.70% | +3.29% |
| Sep 16, 2026 | $0.07 | -94.13% | $0.34 | -97.04% | +2.91% |
| Sep 15, 2026 | $0.04 | -96.08% | $0.34 | -97.04% | +0.96% |
| Sep 14, 2026 | $0.05 | -96.04% | $0.39 | -96.65% | +0.61% |
| Sep 11, 2026 | $0.05 | -95.53% | $0.36 | -96.90% | +1.37% |
| Sep 10, 2026 | $0.05 | -95.61% | $0.42 | -96.32% | +0.71% |
| Sep 09, 2026 | $0.05 | -95.88% | $0.35 | -96.96% | +1.08% |
| Sep 08, 2026 | $0.04 | -96.23% | $0.35 | -97.00% | +0.77% |
| Sep 04, 2026 | $0.07 | -93.52% | $0.35 | -96.94% | +3.42% |
| Sep 03, 2026 | $0.12 | -89.65% | $0.35 | -96.94% | +7.29% |
Page 1 of 8